The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Prenatal and Newborn Genetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028

Global Prenatal and Newborn Genetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028

Publishing Date : Feb, 2022

License Type :
 

Report Code : 1649811

No of Pages : 113

Synopsis
The Prenatal and Newborn Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prenatal and Newborn Genetic Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Prenatal and Newborn Genetic Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Array-Comparative Genetic Hybridization(aCGH) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Prenatal and Newborn Genetic Testing include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, and IntegraGen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prenatal and Newborn Genetic Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Array-Comparative Genetic Hybridization(aCGH)
Fluorescence In-Situ Hybridization(FISH)
Polymerase Chain Reaction(PCR)
Market segment by Application, can be divided into
Hospitals
Diagnostic Organization
Other
Market segment by players, this report covers
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prenatal and Newborn Genetic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prenatal and Newborn Genetic Testing, with revenue, gross margin and global market share of Prenatal and Newborn Genetic Testing from 2019 to 2022.
Chapter 3, the Prenatal and Newborn Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prenatal and Newborn Genetic Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Prenatal and Newborn Genetic Testing research findings and conclusion, appendix and data source.

Geographical Area
Global
Index
1 Market Overview
1.1 Product Overview and Scope of Prenatal and Newborn Genetic Testing
1.2 Classification of Prenatal and Newborn Genetic Testing by Type
1.2.1 Overview: Global Prenatal and Newborn Genetic Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type in 2021
1.2.3 Array-Comparative Genetic Hybridization(aCGH)
1.2.4 Fluorescence In-Situ Hybridization(FISH)
1.2.5 Polymerase Chain Reaction(PCR)
1.3 Global Prenatal and Newborn Genetic Testing Market by Application
1.3.1 Overview: Global Prenatal and Newborn Genetic Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic Organization
1.3.4 Other
1.4 Global Prenatal and Newborn Genetic Testing Market Size & Forecast
1.5 Global Prenatal and Newborn Genetic Testing Market Size and Forecast by Region
1.5.1 Global Prenatal and Newborn Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Prenatal and Newborn Genetic Testing Market Size by Region, (2017-2022)
1.5.3 North America Prenatal and Newborn Genetic Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Prenatal and Newborn Genetic Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size and Prospect (2017-2028)
1.5.6 South America Prenatal and Newborn Genetic Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prenatal and Newborn Genetic Testing Market Drivers
1.6.2 Prenatal and Newborn Genetic Testing Market Restraints
1.6.3 Prenatal and Newborn Genetic Testing Trends Analysis
2 Company Profiles
2.1 Roche Diagnostic
2.1.1 Roche Diagnostic Details
2.1.2 Roche Diagnostic Major Business
2.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
2.1.4 Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Diagnostic Recent Developments and Future Plans
2.2 Elitech Group
2.2.1 Elitech Group Details
2.2.2 Elitech Group Major Business
2.2.3 Elitech Group Prenatal and Newborn Genetic Testing Product and Solutions
2.2.4 Elitech Group Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Elitech Group Recent Developments and Future Plans
2.3 Myriad Genetics
2.3.1 Myriad Genetics Details
2.3.2 Myriad Genetics Major Business
2.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Product and Solutions
2.3.4 Myriad Genetics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Myriad Genetics Recent Developments and Future Plans
2.4 Biocartis
2.4.1 Biocartis Details
2.4.2 Biocartis Major Business
2.4.3 Biocartis Prenatal and Newborn Genetic Testing Product and Solutions
2.4.4 Biocartis Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Biocartis Recent Developments and Future Plans
2.5 IntegraGen
2.5.1 IntegraGen Details
2.5.2 IntegraGen Major Business
2.5.3 IntegraGen Prenatal and Newborn Genetic Testing Product and Solutions
2.5.4 IntegraGen Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 IntegraGen Recent Developments and Future Plans
2.6 Perkin Elmer
2.6.1 Perkin Elmer Details
2.6.2 Perkin Elmer Major Business
2.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Product and Solutions
2.6.4 Perkin Elmer Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Perkin Elmer Recent Developments and Future Plans
2.7 WaferGen Biosystem
2.7.1 WaferGen Biosystem Details
2.7.2 WaferGen Biosystem Major Business
2.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Product and Solutions
2.7.4 WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 WaferGen Biosystem Recent Developments and Future Plans
2.8 Interpace Diagnostics
2.8.1 Interpace Diagnostics Details
2.8.2 Interpace Diagnostics Major Business
2.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.8.4 Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Interpace Diagnostics Recent Developments and Future Plans
2.9 Quest Diagnostic
2.9.1 Quest Diagnostic Details
2.9.2 Quest Diagnostic Major Business
2.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
2.9.4 Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Quest Diagnostic Recent Developments and Future Plans
2.10 Bio-Rad
2.10.1 Bio-Rad Details
2.10.2 Bio-Rad Major Business
2.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Product and Solutions
2.10.4 Bio-Rad Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bio-Rad Recent Developments and Future Plans
2.11 AutoGenomics
2.11.1 AutoGenomics Details
2.11.2 AutoGenomics Major Business
2.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Product and Solutions
2.11.4 AutoGenomics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 AutoGenomics Recent Developments and Future Plans
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Prenatal and Newborn Genetic Testing Product and Solutions
2.12.4 Abbott Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Abbott Recent Developments and Future Plans
2.13 Cepheid
2.13.1 Cepheid Details
2.13.2 Cepheid Major Business
2.13.3 Cepheid Prenatal and Newborn Genetic Testing Product and Solutions
2.13.4 Cepheid Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Cepheid Recent Developments and Future Plans
2.14 EKF Diagnostics
2.14.1 EKF Diagnostics Details
2.14.2 EKF Diagnostics Major Business
2.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.14.4 EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 EKF Diagnostics Recent Developments and Future Plans
2.15 Natera
2.15.1 Natera Details
2.15.2 Natera Major Business
2.15.3 Natera Prenatal and Newborn Genetic Testing Product and Solutions
2.15.4 Natera Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Natera Recent Developments and Future Plans
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business
2.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Product and Solutions
2.16.4 Agilent Technologies Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Agilent Technologies Recent Developments and Future Plans
2.17 Illumina
2.17.1 Illumina Details
2.17.2 Illumina Major Business
2.17.3 Illumina Prenatal and Newborn Genetic Testing Product and Solutions
2.17.4 Illumina Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Illumina Recent Developments and Future Plans
2.18 Ariosa Diagnostics
2.18.1 Ariosa Diagnostics Details
2.18.2 Ariosa Diagnostics Major Business
2.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
2.18.4 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Ariosa Diagnostics Recent Developments and Future Plans
2.19 Sequenom
2.19.1 Sequenom Details
2.19.2 Sequenom Major Business
2.19.3 Sequenom Prenatal and Newborn Genetic Testing Product and Solutions
2.19.4 Sequenom Prenatal and Newborn Genetic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Sequenom Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prenatal and Newborn Genetic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Prenatal and Newborn Genetic Testing Players Market Share in 2021
3.2.2 Top 10 Prenatal and Newborn Genetic Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Prenatal and Newborn Genetic Testing Players Head Office, Products and Services Provided
3.4 Prenatal and Newborn Genetic Testing Mergers & Acquisitions
3.5 Prenatal and Newborn Genetic Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prenatal and Newborn Genetic Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Prenatal and Newborn Genetic Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Application (2017-2022)
5.2 Global Prenatal and Newborn Genetic Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Prenatal and Newborn Genetic Testing Revenue by Type (2017-2028)
6.2 North America Prenatal and Newborn Genetic Testing Revenue by Application (2017-2028)
6.3 North America Prenatal and Newborn Genetic Testing Market Size by Country
6.3.1 North America Prenatal and Newborn Genetic Testing Revenue by Country (2017-2028)
6.3.2 United States Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Prenatal and Newborn Genetic Testing Revenue by Type (2017-2028)
7.2 Europe Prenatal and Newborn Genetic Testing Revenue by Application (2017-2028)
7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Country
7.3.1 Europe Prenatal and Newborn Genetic Testing Revenue by Country (2017-2028)
7.3.2 Germany Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
7.3.3 France Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2017-2028)
8.3.2 China Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8.3.5 India Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Prenatal and Newborn Genetic Testing Revenue by Type (2017-2028)
9.2 South America Prenatal and Newborn Genetic Testing Revenue by Application (2017-2028)
9.3 South America Prenatal and Newborn Genetic Testing Market Size by Country
9.3.1 South America Prenatal and Newborn Genetic Testing Revenue by Country (2017-2028)
9.3.2 Brazil Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2017-2028)
10.3.2 Turkey Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Prenatal and Newborn Genetic Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Prenatal and Newborn Genetic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Prenatal and Newborn Genetic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Prenatal and Newborn Genetic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2023-2028)
Table 6. Roche Diagnostic Corporate Information, Head Office, and Major Competitors
Table 7. Roche Diagnostic Major Business
Table 8. Roche Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
Table 9. Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Elitech Group Corporate Information, Head Office, and Major Competitors
Table 11. Elitech Group Major Business
Table 12. Elitech Group Prenatal and Newborn Genetic Testing Product and Solutions
Table 13. Elitech Group Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 15. Myriad Genetics Major Business
Table 16. Myriad Genetics Prenatal and Newborn Genetic Testing Product and Solutions
Table 17. Myriad Genetics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Biocartis Corporate Information, Head Office, and Major Competitors
Table 19. Biocartis Major Business
Table 20. Biocartis Prenatal and Newborn Genetic Testing Product and Solutions
Table 21. Biocartis Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. IntegraGen Corporate Information, Head Office, and Major Competitors
Table 23. IntegraGen Major Business
Table 24. IntegraGen Prenatal and Newborn Genetic Testing Product and Solutions
Table 25. IntegraGen Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Perkin Elmer Corporate Information, Head Office, and Major Competitors
Table 27. Perkin Elmer Major Business
Table 28. Perkin Elmer Prenatal and Newborn Genetic Testing Product and Solutions
Table 29. Perkin Elmer Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. WaferGen Biosystem Corporate Information, Head Office, and Major Competitors
Table 31. WaferGen Biosystem Major Business
Table 32. WaferGen Biosystem Prenatal and Newborn Genetic Testing Product and Solutions
Table 33. WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Interpace Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. Interpace Diagnostics Major Business
Table 36. Interpace Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 37. Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Quest Diagnostic Corporate Information, Head Office, and Major Competitors
Table 39. Quest Diagnostic Major Business
Table 40. Quest Diagnostic Prenatal and Newborn Genetic Testing Product and Solutions
Table 41. Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Major Business
Table 44. Bio-Rad Prenatal and Newborn Genetic Testing Product and Solutions
Table 45. Bio-Rad Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. AutoGenomics Corporate Information, Head Office, and Major Competitors
Table 47. AutoGenomics Major Business
Table 48. AutoGenomics Prenatal and Newborn Genetic Testing Product and Solutions
Table 49. AutoGenomics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Abbott Corporate Information, Head Office, and Major Competitors
Table 51. Abbott Major Business
Table 52. Abbott Prenatal and Newborn Genetic Testing Product and Solutions
Table 53. Abbott Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Cepheid Corporate Information, Head Office, and Major Competitors
Table 55. Cepheid Major Business
Table 56. Cepheid Prenatal and Newborn Genetic Testing Product and Solutions
Table 57. Cepheid Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. EKF Diagnostics Corporate Information, Head Office, and Major Competitors
Table 59. EKF Diagnostics Major Business
Table 60. EKF Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 61. EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Natera Corporate Information, Head Office, and Major Competitors
Table 63. Natera Major Business
Table 64. Natera Prenatal and Newborn Genetic Testing Product and Solutions
Table 65. Natera Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 67. Agilent Technologies Major Business
Table 68. Agilent Technologies Prenatal and Newborn Genetic Testing Product and Solutions
Table 69. Agilent Technologies Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Illumina Corporate Information, Head Office, and Major Competitors
Table 71. Illumina Major Business
Table 72. Illumina Prenatal and Newborn Genetic Testing Product and Solutions
Table 73. Illumina Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Ariosa Diagnostics Corporate Information, Head Office, and Major Competitors
Table 75. Ariosa Diagnostics Major Business
Table 76. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Product and Solutions
Table 77. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Sequenom Corporate Information, Head Office, and Major Competitors
Table 79. Sequenom Major Business
Table 80. Sequenom Prenatal and Newborn Genetic Testing Product and Solutions
Table 81. Sequenom Prenatal and Newborn Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 83. Global Prenatal and Newborn Genetic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 84. Breakdown of Prenatal and Newborn Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Prenatal and Newborn Genetic Testing Players Head Office, Products and Services Provided
Table 86. Prenatal and Newborn Genetic Testing Mergers & Acquisitions in the Past Five Years
Table 87. Prenatal and Newborn Genetic Testing New Entrants and Expansion Plans
Table 88. Global Prenatal and Newborn Genetic Testing Revenue (USD Million) by Type (2017-2022)
Table 89. Global Prenatal and Newborn Genetic Testing Revenue Share by Type (2017-2022)
Table 90. Global Prenatal and Newborn Genetic Testing Revenue Forecast by Type (2023-2028)
Table 91. Global Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022)
Table 92. Global Prenatal and Newborn Genetic Testing Revenue Forecast by Application (2023-2028)
Table 93. North America Prenatal and Newborn Genetic Testing Revenue by Type (2017-2022) & (USD Million)
Table 94. North America Prenatal and Newborn Genetic Testing Revenue by Type (2023-2028) & (USD Million)
Table 95. North America Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022) & (USD Million)
Table 96. North America Prenatal and Newborn Genetic Testing Revenue by Application (2023-2028) & (USD Million)
Table 97. North America Prenatal and Newborn Genetic Testing Revenue by Country (2017-2022) & (USD Million)
Table 98. North America Prenatal and Newborn Genetic Testing Revenue by Country (2023-2028) & (USD Million)
Table 99. Europe Prenatal and Newborn Genetic Testing Revenue by Type (2017-2022) & (USD Million)
Table 100. Europe Prenatal and Newborn Genetic Testing Revenue by Type (2023-2028) & (USD Million)
Table 101. Europe Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022) & (USD Million)
Table 102. Europe Prenatal and Newborn Genetic Testing Revenue by Application (2023-2028) & (USD Million)
Table 103. Europe Prenatal and Newborn Genetic Testing Revenue by Country (2017-2022) & (USD Million)
Table 104. Europe Prenatal and Newborn Genetic Testing Revenue by Country (2023-2028) & (USD Million)
Table 105. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2017-2022) & (USD Million)
Table 106. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Type (2023-2028) & (USD Million)
Table 107. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022) & (USD Million)
Table 108. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Application (2023-2028) & (USD Million)
Table 109. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2017-2022) & (USD Million)
Table 110. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue by Region (2023-2028) & (USD Million)
Table 111. South America Prenatal and Newborn Genetic Testing Revenue by Type (2017-2022) & (USD Million)
Table 112. South America Prenatal and Newborn Genetic Testing Revenue by Type (2023-2028) & (USD Million)
Table 113. South America Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022) & (USD Million)
Table 114. South America Prenatal and Newborn Genetic Testing Revenue by Application (2023-2028) & (USD Million)
Table 115. South America Prenatal and Newborn Genetic Testing Revenue by Country (2017-2022) & (USD Million)
Table 116. South America Prenatal and Newborn Genetic Testing Revenue by Country (2023-2028) & (USD Million)
Table 117. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2017-2022) & (USD Million)
Table 118. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Type (2023-2028) & (USD Million)
Table 119. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2017-2022) & (USD Million)
Table 120. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Application (2023-2028) & (USD Million)
Table 121. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2017-2022) & (USD Million)
Table 122. Middle East & Africa Prenatal and Newborn Genetic Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Prenatal and Newborn Genetic Testing Picture
Figure 2. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Type in 2021
Figure 3. Array-Comparative Genetic Hybridization(aCGH)
Figure 4. Fluorescence In-Situ Hybridization(FISH)
Figure 5. Polymerase Chain Reaction(PCR)
Figure 6. Prenatal and Newborn Genetic Testing Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Diagnostic Organization Picture
Figure 9. Other Picture
Figure 10. Global Prenatal and Newborn Genetic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Prenatal and Newborn Genetic Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2017-2028)
Figure 13. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Region in 2021
Figure 14. North America Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Prenatal and Newborn Genetic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Prenatal and Newborn Genetic Testing Market Drivers
Figure 20. Prenatal and Newborn Genetic Testing Market Restraints
Figure 21. Prenatal and Newborn Genetic Testing Market Trends
Figure 22. Roche Diagnostic Recent Developments and Future Plans
Figure 23. Elitech Group Recent Developments and Future Plans
Figure 24. Myriad Genetics Recent Developments and Future Plans
Figure 25. Biocartis Recent Developments and Future Plans
Figure 26. IntegraGen Recent Developments and Future Plans
Figure 27. Perkin Elmer Recent Developments and Future Plans
Figure 28. WaferGen Biosystem Recent Developments and Future Plans
Figure 29. Interpace Diagnostics Recent Developments and Future Plans
Figure 30. Quest Diagnostic Recent Developments and Future Plans
Figure 31. Bio-Rad Recent Developments and Future Plans
Figure 32. AutoGenomics Recent Developments and Future Plans
Figure 33. Abbott Recent Developments and Future Plans
Figure 34. Cepheid Recent Developments and Future Plans
Figure 35. EKF Diagnostics Recent Developments and Future Plans
Figure 36. Natera Recent Developments and Future Plans
Figure 37. Agilent Technologies Recent Developments and Future Plans
Figure 38. Illumina Recent Developments and Future Plans
Figure 39. Ariosa Diagnostics Recent Developments and Future Plans
Figure 40. Sequenom Recent Developments and Future Plans
Figure 41. Global Prenatal and Newborn Genetic Testing Revenue Share by Players in 2021
Figure 42. Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Prenatal and Newborn Genetic Testing Revenue Market Share in 2021
Figure 44. Global Top 10 Players Prenatal and Newborn Genetic Testing Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Prenatal and Newborn Genetic Testing Revenue Share by Type in 2021
Figure 47. Global Prenatal and Newborn Genetic Testing Market Share Forecast by Type (2023-2028)
Figure 48. Global Prenatal and Newborn Genetic Testing Revenue Share by Application in 2021
Figure 49. Global Prenatal and Newborn Genetic Testing Market Share Forecast by Application (2023-2028)
Figure 50. North America Prenatal and Newborn Genetic Testing Sales Market Share by Type (2017-2028)
Figure 51. North America Prenatal and Newborn Genetic Testing Sales Market Share by Application (2017-2028)
Figure 52. North America Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2017-2028)
Figure 53. United States Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Prenatal and Newborn Genetic Testing Sales Market Share by Type (2017-2028)
Figure 57. Europe Prenatal and Newborn Genetic Testing Sales Market Share by Application (2017-2028)
Figure 58. Europe Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2017-2028)
Figure 59. Germany Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Prenatal and Newborn Genetic Testing Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Prenatal and Newborn Genetic Testing Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Prenatal and Newborn Genetic Testing Revenue Market Share by Region (2017-2028)
Figure 67. China Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Prenatal and Newborn Genetic Testing Sales Market Share by Type (2017-2028)
Figure 74. South America Prenatal and Newborn Genetic Testing Sales Market Share by Application (2017-2028)
Figure 75. South America Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Prenatal and Newborn Genetic Testing Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Prenatal and Newborn Genetic Testing Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Prenatal and Newborn Genetic Testing Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Prenatal and Newborn Genetic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source

Published By : GlobalInfoResearch

Why ‘The Market Reports’